Skip to main content

Table 2 Baseline characteristics and IVF outcomes in women serum TSH concentration did and did not exceed 2.5 mIU/L before the IVF cycle

From: Outcome of in vitro fertilization in women with subclinical hypothyroidism

Characteristics

TSH ≥ 2.5mIU/L

TSH < 2.5mIU/L

P

n = 62

n = 114

 

Age (yrs)

30.48 ± 4.07

29.56 ± 4.37

0.336

BMI(kg/m2)

23.60 ± 4.05

22.29 ± 3.18

0.099

Previous pregnancies

48.4%

54.4%

 

AFC

12.00 ± 5.00

12.00 ± 8.00

0.972

TSH(mIU/L)

2.60,4.21

0.32,1.88

0.0

FT3(pmol/L)

4.73 ± 0.76

5.10 ± 0.99

0.005

FT4(pmol/L)

17.29 ± 2.29

20.10 ± 3.99

0.001

Indication to IVF

  

0.439

Tubal factor infertility

45.2%

52.6%

 

Ovulatory dysfunction

6.4%

8.8%

 

Endometriosis

3.2%

0%

 

Male

12.9%

17.5%

 

Mixed

25.8%

19.3%

 

Unexplained infertility

6.5%

1.8%

 

Protocol of stimulation

   

Long protocol

77.4%

89.5%

 

Short protocol

6.5%

3.5%

 

GnRH antagonists

3.2%

0%

 

ART procedure

  

0.8

IVF

75.8%

70.2%

 

ICSI

24.2%

29.8%

 

Duration of stimulation(Days)

11.23 ± 1.82

11.98 ± 2.09

0.106

Total amount of recombinant FSH administration

2025 ± 825

2475.00 ± 1350.00

0.128

Serum estradiol at HCG Administration(pg/ml)

1983.50 ± 2079

2529.00 ± 2005.00

0.108

Total number of oocytes retrieved

10.00 ± 8.00

11.00 ± 8.00

0.752

Total number of good quality embryos

2.00 ± 3.00

4.00 ± 6.00

0.767

Clinical pregnancies

38.7%

47.4%

0.436

Miscarriages

16.7%

7.4%

0.379

Live birth rate

32.3%

43.9%

0.288

  1. Data are reported as %,mean ± standard deviation or quartile,as appropriate
  2. AFC antral follicle, BMI, body mass index, FSH follicle-stimulating hormone, GnRH gonadotropin-releasing hormone